128 related articles for article (PubMed ID: 6091252)
1. ACTH analogue application to oncostatic chemotherapy. A double blind approach.
Piazza E; Cattaneo MT; Colombo F; Libretti A
Ric Clin Lab; 1984; 14(2):257-9. PubMed ID: 6091252
[No Abstract] [Full Text] [Related]
2. ACTH 1-17 effects in oncology.
Battelli T; Mattioli R; Manocchi P; Giustini L; Ginnetti A; Burattini L
Ric Clin Lab; 1984; 14(2):205-9. PubMed ID: 6091245
[TBL] [Abstract][Full Text] [Related]
3. ACTH 1-17 effects in the chemotherapy of advanced solid tumors.
Barone C; Grieco A; Astone A; Vagliviello L; Garufi C; Greco AV
Ric Clin Lab; 1984; 14(2):211-20. PubMed ID: 6091246
[TBL] [Abstract][Full Text] [Related]
4. Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II study.
Hilkens PH; van der Burg ME; Moll JW; van den Bent MJ; van Putten WL; Vecht CJ
Clin Neurol Neurosurg; 1995 May; 97(2):139-41. PubMed ID: 7656487
[TBL] [Abstract][Full Text] [Related]
5. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
[TBL] [Abstract][Full Text] [Related]
6. The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.
van Gerven JM; Hovestadt A; Moll JW; Rodenburg CJ; Splinter TA; van Oosterom AT; Keizer L; Drogendijk TE; Groenhout CM; Vecht CJ
J Neurol; 1994 Jun; 241(7):432-5. PubMed ID: 7931444
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.
Passalacqua R; Cocconi G; Caminiti C; Silingardi V; Bella MA; Bichisao E; Michiara M; Malavasi V; Donati D; Di Costanzo F; Rocca A; Di Sarra S; Scaglione F; Fraschini F
J Clin Oncol; 1997 Jun; 15(6):2467-73. PubMed ID: 9196163
[TBL] [Abstract][Full Text] [Related]
9. Protection of cisplatin-induced neuropathy: recent developments.
Hamers F; Neijt J; Gispen W
Pathol Biol (Paris); 1992 Nov; 39(9):829-30. PubMed ID: 1311436
[No Abstract] [Full Text] [Related]
10. ACTH 1-17 effects in acute myeloid leukemia.
Arcese W; Nervi C; Avvisati G; Mandelli F
Ric Clin Lab; 1984; 14(2):199-203. PubMed ID: 6091244
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: comparison of placebo vs. adrenocorticotropic hormone (ACTH).
Passalacqua R; Cocconi G; Bella M; Monici L; Michiara M; Bandini N; Bacchi M
Ann Oncol; 1992 Jun; 3(6):481-5. PubMed ID: 1323324
[TBL] [Abstract][Full Text] [Related]
12. Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting.
Colbert N; Izrael V; Lotz JP; Stoppa-Lyonnet D; Vannetzel JM; Pene F; Schlienger M; Laugier A
J Clin Oncol; 1983 Oct; 1(10):635-9. PubMed ID: 6321674
[TBL] [Abstract][Full Text] [Related]
13. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
[No Abstract] [Full Text] [Related]
14. A review of the use of chemoprotectants in cancer chemotherapy.
Lewis C
Drug Saf; 1994 Sep; 11(3):153-62. PubMed ID: 7811398
[TBL] [Abstract][Full Text] [Related]
15. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
Bravenboer B; Erkelens DW; Gispen WH
Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372
[No Abstract] [Full Text] [Related]
16. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ACTH 4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis.
Butter HJ; Lapierre Y; Firestone P; Blank A
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):661-4. PubMed ID: 6099589
[TBL] [Abstract][Full Text] [Related]
18. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic effects of ACTH/MSH neuropeptides.
de Wied D
Acta Neurobiol Exp (Wars); 1990; 50(4-5):353-66. PubMed ID: 1966658
[TBL] [Abstract][Full Text] [Related]
20. ACTH 1-17 effects in multiple sclerosis.
Marforio S
Ric Clin Lab; 1984; 14(2):253-5. PubMed ID: 6091251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
